News | November 15, 2006

Breakthrough Algorithms Predict Sudden Cardiac Death Risk

Breakthrough Algorithms Predict Sudden Cardiac Death Risk

AHA in Chicago: GE Healthcare announced this week that it is the only company with two patented algorithms that meet new MN guidelines that help physicians predict whether a patient is at risk for sudden cardiac death (SCD).

“It is GE’s hope that the wealth of detailed, accurate cardiac information provided by these algorithms will help physicians better understand which patients are at highest risk for SCD and enable them to prescribe proactive treatments that can help reduce these deaths,” said Dr. Matthias Weber, vice president of GE Healthcare’s Diagnostic Cardiology business.

When inputted with ambulatory (Holter) electrocardiography (ECG) data, GE’s patented, breakthrough algorithms — Marquette Modified Moving Average (MMA) T-Wave Alternans algorithm and the Marquette Heart Rate Turbulence algorithm –have been shown to help predict if a person is at risk for SCD. A cardiac stress test, when conducted with GE’s CASE stress test system and CardioSoft software, uses the MMA T-Wave Alternans algorithm to evaluate a patient’s risk of SCD.

GE’s Heart Rate Turbulence algorithm measures and compares the heart rate before and after premature beats, providing comparison data used to measure how the patient’s heart and autonomic nervous system work together, which can determine cardiac health.

“Used together, these algorithms interpret complex cardiac rhythms that provide a more accurate, advanced way to determine which patients are at risk for SCD and would benefit most from a implantable defibrillator,” said Dr. Richard L. Verrier, associate professor of Medicine, Harvard Medical School and Beth Israel Deaconess Medical Center. “This noninvasive and portable method for diagnosing patients should significantly benefit those patients who may be at higher risk for SCD or help in prescribing the most appropriate therapies to prevent SCD.”

For more information visit www.gehealthcare.com.

Related Content

AUM Cardiovascular Receives FDA Approval for CADence ECG Device
Technology | ECG| August 08, 2017
AUM Cardiovascular announced it has received clearance from the U.S. Food and Drug Administration (FDA) for CADence, a...
More Than 20 Percent of Low-Risk Patients Receive Annual ECG
News | ECG| July 20, 2017
July 20, 2017 — More than one in five Ontario patients receive an ...
Cardiologs ECG Analysis Platform Receives FDA Clearance
Technology | ECG Monitoring Services| July 13, 2017
Cardiologs Technologies SAS announced that it has received U.S. Food and Drug Administration (FDA) clearance of its...
iRhythm and Stanford Researchers Develop Deep Learning-Based Cardiac Arrhthymia Detection Algorithm
News | Artificial Intelligence| July 11, 2017
iRhythm Technologies Inc. announced a collaboration with the Stanford Machine Learning Group that has resulted in the...
Abbott SJM Confirm RX Implantable cardiac monitor gains european CE mark approval
News | May 30, 2017
May 30, 2017 — Abbott recently announced European CE mark and first use of the new Confirm Rx Insertable Cardiac Moni
Medtronic Reveal Linq implantable cardiac monitor

The Medtronic Reveal Linq implantable cardiac monitor is the smallest implantable monitor on the market. It is used as a long-term Holter monitor for 24-hour a day, 365-day a year patient monitoring. The device uses wireless connectivity to download the patient data with a patient bedside base unit to send the information over the internet so it is accessible by physicians.

Feature | Atrial Fibrillation| May 16, 2017
May 16, 2017 - The study using small, subcutaneous implantable cardiac monitors for long-term, 24-hour a day monitori
Sponsored Content | Videos | EP Mapping and Imaging Systems| February 01, 2017
This video, provided by Medtronic, demonstrates the CardioInsight electro-anatomical mapping system.
medtronic cardioinsight electromapping system, electoanatomical mapping, noninvasive ep mapping

A screen shot of the waveforms and the the 3-D electo-mapping models created using the noninvasive CardioInsight system.

Technology | EP Mapping and Imaging Systems| February 01, 2017
February 1, 2017 — Medtronic received U.S.
Heart Test Laboratories, HTL, MyoVista ECG, common stock offering
News | ECG| January 31, 2017
Heart Test Laboratories Inc. (HTL) has successfully raised $12 million by way of a Common Stock private placement...
Overlay Init